MLK3 promotes atherosclerosis by regulating ferroptosis in macrophages

Hongkui Chen1,2, Jiabin Tu1,2, Ziqing Ruan1,2

  • 1Department of Cardiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.

Abstract

Insights

Mixed lineage kinase 3 (MLK3) drives atherosclerosis by promoting macrophage ferroptosis via JNK/p53 signaling. Elevated plasma MLK3 levels indicate its role in cardiovascular disease progression.

Area of Science:

  • Cardiovascular Biology
  • Cellular Pathology
  • Molecular Medicine

Background:

  • Atherosclerosis (AS) is a leading global cause of cardiovascular death.
  • Macrophage ferroptosis is a key process in AS development.
  • The role of mixed lineage kinase 3 (MAP3K11, MLK3) in macrophage ferroptosis during AS remains unclear.

Purpose of the Study:

  • To elucidate the mechanism by which MLK3 regulates macrophage ferroptosis in atherosclerosis.
  • To investigate MLK3 as a potential therapeutic target for AS.

Main Methods:

  • Analysis of bulk and single-cell RNA-sequencing data from vascular tissues.
  • In vitro studies using macrophages treated with oxidized low-density lipoprotein (ox-LDL) or erastin.
  • In vivo assessment in animal models of AS, including ferroptosis and JNK/p53 pathway activation.
  • Clinical plasma MLK3 level assays in AS patients.

Main Results:

  • MLK3 is highly expressed in atherosclerotic plaque macrophages and upregulated by ox-LDL.
  • MLK3 knockdown inhibited ox-LDL-induced, but not erastin-induced, macrophage ferroptosis.
  • MLK3 promotes JNK/p53 signaling, leading to increased ferroptosis, plaque area, and collagen deposition in AS models.
  • Elevated plasma MLK3 levels were observed in patients with AS.

Conclusions:

  • MLK3 accelerates atherosclerotic lesion development by inducing macrophage ferroptosis.
  • The JNK/p53 signaling pathway is critical for MLK3-mediated ferroptosis in AS macrophages.
  • Plasma MLK3 may serve as a biomarker for AS.